HMGCR and cardiovascular disorder: Statins are a class of cholesterol‐lowering drugs that reduce cardiovascular diseases by blocking HMGCR, a rate‐controlling enzyme of the MVA pathway (Appendix Fig S3) (Mullen et al, 2016; Iannelli et al, 2018).